Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Awards VisiGen $100K SBIR for New Biomolecule-Labeling Method

NEW YORK, Sept. 26 (GenomeWeb News) - VisiGen Biotechnologies said today that it has won a Phase 1 Small Business Innovation Research grant from the National Institute of Health's National Institute of General Medical Sciences to develop a new method for labeling DNA, RNA, and proteins.

 

The company did not provide the amount of the grant, but an NIH database lists VisiGen as the recipient of a $100,000 award for a project entitled, "Novel Biolabeling Methods and Reagents."

 

An abstract for the project describes the technology as a "set of novel ATP-fluorescent-dye molecules and ATP-biotin molecules ... for the enzymatic, 5'-end-labeling of an oligonucleotide," and notes that the goal of the Phase I project "is to examine the labeling efficiencies of a library of labeled ATP variants and define the critical threshold for obtaining robust and reproducible signal intensities from labeled-targets hybridized to a microarray."

 

According to the company, the method can be used to directly label RNA for microarray experiments "at a fraction of the cost of current labeling methods" and also has "interesting applications" for the analysis of microRNA.

 

In August, VisiGen was awarded a three-year, $4.2 million grant by the National Human Genome Research Institute as part of its latest round of sequencing technology grants.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.